Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 11 papers. Top paper: “Phase 1 dose escalation trial of the selective adenosine A2B antagonist PBF-1129 in patients with metastatic non-small cell lung cancer”.
Ruohan Wu, Lai Wei, Mikhail M. Dikov, Shankar Suman, Po‐Lan Su +17 more
Meena Choi, Sara L. Sinicropi-Yao, Katie Lomeo, Joseph M. Amann, Emanuela Felley‐Bosco +7 more
Konstantin Shilo, Joseph M. Amann, Alyssa Shulman, Mohammad Hojjat‐Farsangi, Håkan Mellstedt +4 more
Bernice A. Agana, Jacob M. Kaufman, Michael F. Sharpnack, Walter Wang, Christoph Weigel +9 more
Xinyu Wang, Kwang Joo Kwak, Jingjing Zhang, Tamio Okimoto, Joseph M. Amann +12 more
Shankar Suman, Joseph M. Amann, Ruohan Wu, David P. Carbone, Jie Wang +2 more
Shankar Suman, Mounika Goruganthu, Elena E. Tchekneva, Shuxiao Guan, Rajeswara Rao Arasada +28 more
Bernice A. Agana, Jacob M. Kaufman, Michael F. Sharpnack, Walter Wang, Christoph Weigel +9 more
Yasuko Kajimura, Lara Rizzotto, Anna Tessari, Shimaa Soliman, Rosa Visone +14 more
Vikas Ghai, Joseph M. Amann, Tamio Okimoto, Konstantin Shilo, Taek‐Kyun Kim +3 more
Shuxin Dong, Anna Tessari, Arturo Orlacchio, Alexandra Thoms, Maria Concetta Cufaro +18 more